C07D 209/64
With an oxygen atom in position 1
Official title: with an oxygen atom in position 1
C07D209/64 (With an oxygen atom in position 1) appears on 23 US grants and 25 published applications in this corpus.
Search patents in C07D- Granted patents
- 23
- Published applications
- 25
- Assignees
- 18
- Inventors
- 84
- Latest grant
- 22 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 2 |
| 2005 | 1 | 1 |
| 2006 | 0 | 2 |
| 2007 | 2 | 1 |
| 2008 | 0 | 4 |
| 2009 | 1 | 4 |
| 2010 | 2 | 2 |
| 2011 | 2 | 1 |
| 2012 | 1 | 0 |
| 2013 | 1 | 1 |
| 2014 | 2 | 2 |
| 2015 | 2 | 1 |
| 2016 | 1 | 2 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods and compounds for restoring mutant p53 function22 Aug 2023US 11,731,953 B2Pmv Pharmaceuticals, Inc.
- Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors25 Apr 2017US 9,630,921 B2Janssen Pharmaceutica NV
- Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors23 Aug 2016US 9,422,284 B2Janssen Pharmaceutica NV
- N-linked lactam M1 receptor positive allosteric mogulators8 Dec 2015US 9,206,200 B2Merck Sharp & Dohme Corp.
- Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors6 Oct 2015US 9,150,512 B2Janssen Pharmaceutica NV
- Methods and compounds for restoring mutant p53 function23 Feb 2023US 2023/0056253 A1Pmv Pharmaceuticals, Inc.
- Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors3 Nov 2016US 2016/0318865 A1Janssen Pharmaceutica NV
- Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors7 Jan 2016US 2016/0002229 A1Janssen Pharmaceutica NV
- N-linked lactam m1 receptor positive allosteric modulators5 Mar 2015US 2015/0065498 A1Merck Sharp & Dohme Corp.
- Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors26 Jun 2014US 2014/0179732 A1Janssen Pharmaceutica NV
Most cited
By later US patents
- Naphtholactams and lactones as bone morphogenetic protein active agents119US 6,030,967 ATakeda Chemical Industries, Ltd. · 2000
- Antithrombotic agents30US 6,313,122 B1Eli Lilly and Company · 2001
- Antithrombotic agents9US 6,605,626 B2Eli Lilly and Company · 2003
- Tetrahydrocyclopent[B]indole methanamines and related compounds8US 5,350,762 AHoechst-Roussel Pharmaceuticals Inc. · 1994
- Antiasthmatic 5,6-benzoisoindoline compositions6US 3,973,030 ACiba-Geigy Corporation · 1976